Stada said to be working with Goldman Sachs on "strategic options"; predators circle - sources
According to two sources familiar with the matter, generic drug group Stada is said to be working with bankers from Goldman Sachs after receiving informal expressions of interest from potential acquirers.
Date:Thursday, 08 December 2016 5:32 pm
